Correlation Between Oncorus and Biodexa Pharmaceticals
Can any of the company-specific risk be diversified away by investing in both Oncorus and Biodexa Pharmaceticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncorus and Biodexa Pharmaceticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncorus and Biodexa Pharmaceticals, you can compare the effects of market volatilities on Oncorus and Biodexa Pharmaceticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncorus with a short position of Biodexa Pharmaceticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncorus and Biodexa Pharmaceticals.
Diversification Opportunities for Oncorus and Biodexa Pharmaceticals
0.53 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Oncorus and Biodexa is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Oncorus and Biodexa Pharmaceticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biodexa Pharmaceticals and Oncorus is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncorus are associated (or correlated) with Biodexa Pharmaceticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biodexa Pharmaceticals has no effect on the direction of Oncorus i.e., Oncorus and Biodexa Pharmaceticals go up and down completely randomly.
Pair Corralation between Oncorus and Biodexa Pharmaceticals
If you would invest 4.35 in Oncorus on September 30, 2024 and sell it today you would earn a total of 0.00 from holding Oncorus or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 1.56% |
Values | Daily Returns |
Oncorus vs. Biodexa Pharmaceticals
Performance |
Timeline |
Oncorus |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Biodexa Pharmaceticals |
Oncorus and Biodexa Pharmaceticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Oncorus and Biodexa Pharmaceticals
The main advantage of trading using opposite Oncorus and Biodexa Pharmaceticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncorus position performs unexpectedly, Biodexa Pharmaceticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biodexa Pharmaceticals will offset losses from the drop in Biodexa Pharmaceticals' long position.Oncorus vs. Apollomics Class A | Oncorus vs. Pyxis Oncology | Oncorus vs. Zura Bio Limited | Oncorus vs. Altamira Therapeutics |
Biodexa Pharmaceticals vs. Where Food Comes | Biodexa Pharmaceticals vs. flyExclusive, | Biodexa Pharmaceticals vs. Tyson Foods | Biodexa Pharmaceticals vs. SFL Corporation |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
CEOs Directory Screen CEOs from public companies around the world | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data |